BIOMAT Database Logo BIOMAT Database Logo

[Controlled rifampicin and ethambutol therapy of chronic destructive pulmonary tuberculosis in a rural district]. 1976

E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000553 Ambulatory Care Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility. Outpatient Care,Outpatient Health Services,Clinic Visits,Health Services, Outpatient,Outpatient Services,Services, Outpatient Health,Urgent Care,Care, Ambulatory,Care, Outpatient,Care, Urgent,Cares, Urgent,Clinic Visit,Health Service, Outpatient,Outpatient Health Service,Outpatient Service,Service, Outpatient,Service, Outpatient Health,Services, Outpatient,Urgent Cares,Visit, Clinic,Visits, Clinic
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
June 1980, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
March 1981, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
January 1971, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Rifampicin and ethambutol in the treatment of chronic, destructive forms of pulmonary tuberculosis].
January 1972, Giornale italiano di chemioterapia,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
January 1971, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
November 1976, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].
January 1976, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
January 1972, Problemy tuberkuleza,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
January 1973, Scandinavian journal of respiratory diseases,
E A Stoianovskiĭ, and B A Abrarov, and Z I Iusman, and A G Ganiev, and D K Mirzakhalov
[Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
January 1975, Problemy tuberkuleza,
Copied contents to your clipboard!